Reference genome (total # of gene products) | phiCD119 (53325Â bp) | phiC2 (56,538Â bp) | EJ-1 (42935Â bp) | KC5a (38239Â bp) | AQ113 (36566Â bp) | Abouo (45552Â bp) | Davies (58572Â bp) | Jimmer1/2 (54312Â bp) |
---|---|---|---|---|---|---|---|---|
phiCD119 (79 gp) | 79 (100.00%)* | Â | Â | Â | Â | Â | Â | |
phiC2 (82 gp) | 40 (50.63%) | 82 (100%) | Â | Â | Â | Â | Â | Â |
phiCD27 (75 gp) | 29 (36.71%) | 41 (50%) | Â | Â | Â | Â | Â | Â |
EJ-1 (73 gp) | 12 (15.19%) | 19 (23.17%) | 73 (100%) | Â | Â | Â | Â | Â |
KC5a (61 gp) | 17 (21.52%) | 20 (24.39%) | 19 (26.03%) | 61 (100%) | Â | Â | Â | Â |
AQ113 (56 gp) | 16 (20.25%) | 19 (23.17%) | 18 (24.66%) | 28 (45.9%) | 56 (100%) | Â | Â | Â |
Abouo (94 gp) | 19 (24.05%) | 25 (30.49%) | 21 (28.77%) | 19 (31.35%) | 19 (33.93%) | 94 (100%) | Â | Â |
Davies (94 gp) | 20 (25.32%) | 26 (31.71%) | 21 (28.77%) | 19 (31.35%) | 19 (33.93%) | 85 (90.43%) | 94 (100%) | Â |
Jimmer1/2 (102 gp) | 19 (24.05%) | 26 (31.71%) | 20 (27.4%) | 19 (31.35%) | 18 (32.14%) | 62 (65.96%) | 65 (69.15%) | 102 (100%) |
Emery (102 gp) | 7 (8.86%) | 4 (4.88%) | 5 (6.85%) | 5 (8.2%) | 3 (5.36%) | 10 (10.64%) | 12 (12.77%) | 9 (8.82%) |